Our industry leading biomimetic platforms enable us to work with our clients and partners to apply predictive data assisting in identification of better drug candidates, earlier, and more accurately and efficiently. AxoSim’s NerveSim®, BrainSim® and microBrain™ platforms are revolutionizing the way that biopharmaceutical companies develop neurological drugs.